| Common Name | MRA, atlizumab, rhPM-1 |
|---|---|
| Conjugate | Unconjugated |
| Synonyms | CD126;gp80;IL-6R-1;IL-6RA;IL6Q;IL6RA;IL6RQ |
| Applications | ELISA; Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000; Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Humanized |
| IgG type | Human IgG1 – kappa |
| Reactivity | Human |
| Target | |
| Uniprot ID | P08887 |
| Description | Anti-IL6R (tocilizumab biosimilar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
服务热线
400-006-0995
18062749453
